Phil King’s investment firm was the largest shareholder in Opthea, the eye treatment play who warned it could be insolvent ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Investing.com -- Shares of Impact BioMedical Inc. (NYSE American: IBO) skyrocketed, more than doubling in value during the recent trading session. The biotechnology firm’s stock rose over 150%, a ...

TC Biopharm shares are trading lower by 64% during Friday's session. The company announced the transition from Nasdaq to OTC ...

Opus Genetics, Inc. ("Opus” or the "Company”) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing ...

Holding Bitcoin could help biotech firms survive the long period of time it takes to bring products to market, says Atai Life ...

Nifty 50 was trading at 23190.65 (1.24%). Today Nifty 50 has been trading in the range of 23216.70 to 22973.95. Nifty futures are at 23191.00 (0.95%) & with an open interest change of -1.98% which ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Discover three undervalued biotech stocks with strong assets, solid cash reserves, and major catalysts ahead. Click for the ...

The top meme coins to invest in now are here! Osaka Protocol, PYTHIA, and BobaCat are on fire—get huge gains before the next ...

Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's shareholders ...

The Federal Reserve lifted confidence amid economic uncertainty, sparking optimism in the U.S. stock market. Chair Jerome ...